Status:
UNKNOWN
Mini-AFTERc Intervention for Fear of Cancer Recurrence
Lead Sponsor:
University of St Andrews
Collaborating Sponsors:
University of Stirling
University of Surrey
Conditions:
Breast Cancer
Fear of Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
People treated for breast cancer often live with an ongoing fear that the cancer will recur. This fear may develop and impact on their mental health and quality of life. The Mini-AFTERc study is a pil...
Detailed Description
The objectives of this pilot trial are as follows: 1. To develop a procedure for training breast cancer nurses (BCN) in the delivery of the Mini-AFTERc intervention and introduce the intervention int...
Eligibility Criteria
Inclusion
- Patient inclusion criteria for screening:
- Completed primary cancer treatment.
- Cancer-free.
- Female.
- Responsible clinician agrees to their participation.
- Patient inclusion criteria for trial:
- Score 'moderate' (≥10 and \<15) on the Fear of Cancer Recurrence 4-item scale (FCR4) during screening.
- Patient exclusion criteria:
- Not completed primary cancer treatment.
- Not cancer-free.
- Male.
- A diagnosed psychotic disorder, known to the cancer service, for which the patient is currently receiving treatment.
Exclusion
Key Trial Info
Start Date :
June 13 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
133 Patients enrolled
Trial Details
Trial ID
NCT03763825
Start Date
June 13 2019
End Date
September 1 2020
Last Update
May 31 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Margaret Hospital
Dunfermline, NHS Fife, United Kingdom, KY12 0SU
2
Raigmore Hospital
Inverness, NHS Highlands, United Kingdom, IV2 3UJ
3
Western General Hospital
Edinburgh, NHS Lothain, United Kingdom, EH4 2XU
4
Perth Royal Infirmary
Perth, NHS Tayside, United Kingdom, PH1 1NX